Chin B. Eap

13.2k total citations · 1 hit paper
288 papers, 9.2k citations indexed

About

Chin B. Eap is a scholar working on Psychiatry and Mental health, Pharmacology and Pharmacology. According to data from OpenAlex, Chin B. Eap has authored 288 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Psychiatry and Mental health, 63 papers in Pharmacology and 61 papers in Pharmacology. Recurrent topics in Chin B. Eap's work include Pharmacogenetics and Drug Metabolism (62 papers), Schizophrenia research and treatment (44 papers) and Pharmacological Effects and Toxicity Studies (42 papers). Chin B. Eap is often cited by papers focused on Pharmacogenetics and Drug Metabolism (62 papers), Schizophrenia research and treatment (44 papers) and Pharmacological Effects and Toxicity Studies (42 papers). Chin B. Eap collaborates with scholars based in Switzerland, France and United States. Chin B. Eap's co-authors include Pierre Baumann, Thierry Buclin, Séverine Crettol, Nicolas Ansermot, Muriel Noetzli, Kerry Powell, Guido Bondolfi, Laurent A. Décosterd, Amalio Telenti and Chantal Csajka and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chin B. Eap

267 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

2002 535 citations Catia Marzolini, Thierry Buclin et al. profile →

Peers

Countries citing papers authored by Chin B. Eap

Since Specialization

Citations

This map shows the geographic impact of Chin B. Eap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin B. Eap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin B. Eap more than expected).

Fields of papers citing papers by Chin B. Eap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin B. Eap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin B. Eap. The network helps show where Chin B. Eap may publish in the future.

Co-authorship network of co-authors of Chin B. Eap

This figure shows the co-authorship network connecting the top 25 collaborators of Chin B. Eap. A scholar is included among the top collaborators of Chin B. Eap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin B. Eap. Chin B. Eap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study 2024 ·Frontiers in Pharmacology ·(unknown), Marco Ferrari, Giorgio Pistis, Franziska Gamma, Franca Marino, Armin von Gunten, Philippe Conus, Marco Cosentino, Chin B. Eap	4
2	Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients 2024 ·Frontiers in Psychiatry ·(unknown), Isabella Locatelli, (unknown), (unknown), (unknown), Setareh Ranjbar, Martin Preisig, (unknown), Armin von Gunten, Philippe Conus, Chin B. Eap	1
3	Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohort 2024 ·Translational Psychiatry ·(unknown), Jue Lin, Marie C. Sadler, Setareh Ranjbar, (unknown), (unknown), Martin Preisig, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Zoltán Kutalik, Chin B. Eap	0
4	Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study 2024 ·Nicotine & Tobacco Research ·(unknown), (unknown), (unknown), (unknown), Felix Hammann, Vera van der Velpen, Chin B. Eap, Neal L. Benowitz, Manuel Haschke, Evangelia Liakoni	8
5	Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort 2024 ·Translational Psychiatry ·Jessica Mwinyi, Marie‐Pierre F. Strippoli, (unknown), Helgi B. Schiöth, Chin B. Eap, Aurélie M. Lasserre, Pedro Marques‐Vidal, Caroline L. Vandeleur, Martin Preisig	0
6	Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project 2023 ·Frontiers in Psychiatry ·(unknown), (unknown), Chin B. Eap, Céline J. Fischer Fumeaux, Myriam Bickle Graz, Mathilde Morisod Harari, (unknown), Peggy Gandia, Karel Allegaert, Hedvig Nordeng, Jean‐Michel Hascoët, Olivier Claris, Manuella Epiney, Chantal Csajka, Monia Guidi, Ema Ferreira, Alice Panchaud	1
7	CYP2C19 expression modulates affective functioning and hippocampal subiculum volume—a large single-center community-dwelling cohort study 2022 ·Translational Psychiatry ·(unknown), (unknown), Mehdi Gholam‐Rezaee, Marie‐Pierre F. Strippoli, Ferath Kherif, Antoine Lutti, Martin Preisig, Bogdan Draganski, Chin B. Eap	2
8	Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution 2021 ·Clinical and Translational Science ·(unknown), (unknown), Mehdi Gholam‐Rezaee, Benjamin Hennart, (unknown), Marc Augsburger, Armin von Gunten, Philippe Conus, Delphine Allorge, Aurélien Thomas, Chin B. Eap	3
9	Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort 2021 ·Translational Psychiatry ·(unknown), Mehdi Gholam‐Rezaee, Jennifer Sjaarda, (unknown), (unknown), (unknown), (unknown), Radoslaw Panczak, Christoph U. Correll, Alessandra Solida, Kerstin Jessica Plessen, Armin von Gunten, Zoltán Kutalik, Philippe Conus, Chin B. Eap	7
10	Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort 2021 ·Translational Psychiatry ·(unknown), Mehdi Gholam‐Rezaee, Jennifer Sjaarda, (unknown), (unknown), (unknown), (unknown), Radoslaw Panczak, Christoph U. Correll, Alessandra Solida, Kerstin Jessica Plessen, Armin von Gunten, Zoltán Kutalik, Philippe Conus, Chin B. Eap	0
11	Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug–drug interactions and probability of target attainment 2019 ·British Journal of Clinical Pharmacology ·Perrine Courlet, Monia Guidi, (unknown), (unknown), Matthias Cavassini, Thierry Buclin, Catia Marzolini, Chin B. Eap, Laurent A. Décosterd, Chantal Csajka, (unknown)	8
12	Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression 2017 ·Translational Psychiatry ·(unknown), D Sciarra, J. Petit, Chin B. Eap, Olivier Halfon, Pierre J. Magistretti, Benjamin Boutrel, Jean‐René Cardinaux	13
13	Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. 2017 ·Experimental and Clinical Psychopharmacology ·(unknown), Maria Dobrinas, Mehdi Gholam‐Rezaee, Rubin Lubomirov, Jacques Cornuz, Chantal Csajka, Chin B. Eap	12
14	Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs 2017 ·Gene ·(unknown), (unknown), Frederik Vandenberghe, (unknown), (unknown), Lina Quteineh, Mehdi Gholam‐Rezaee, Wassim Raffoul, Lee Ann Applegate, Paris Jafari, Franziska Gamma, Armin von Gunten, Philippe Conus, Chin B. Eap	5
15	Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments 2015 ·Journal of Clinical Psychopharmacology ·(unknown), Frederik Vandenberghe, (unknown), Lina Quteineh, Eva Choong, Mehdi Gholam‐Rezaee, Pierre J. Magistretti, Jean‐Michel Aubry, Armin von Gunten, Martin Preisig, Enrique Castelao, Péter Vollenweider, Gérard Waeber, Zoltán Kutalik, Philippe Conus, Chin B. Eap	5
16	ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment 2006 ·Clinical Pharmacology & Therapeutics ·Séverine Crettol, Julien Déglon, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Isabelle Gothuey, Martine Monnat, Chin B. Eap	190
17	Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment 2005 ·Clinical Pharmacology & Therapeutics ·Séverine Crettol, Julien Déglon, Jacques Besson, (unknown), Isabelle Gothuey, Robert Hämmig, Martine Monnat, (unknown), Pierre Baumann, Chin B. Eap	187
18	Clinical pharmacokinetics of SSRIs 1999 ·IRIS ·Pierre Baumann, Chin B. Eap, Pierre Voirol	0
19	Ultraschnelle Metabolisierer. Grundlagen und klinische Bedeutung 1999 ·IRIS ·Pierre Baumann, Chin B. Eap, (unknown), Markus Kosel, Pierre Voirol	0
20	Alpha1-acid glycoprotein: genetics, biochemistry, physiological functions and pharmacology 1989 ·IRIS ·Pierre Baumann, Chin B. Eap, Wernér E.G. Müller, Jean‐Paul Tillement	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact